Navigation Links
Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
Date:12/27/2011

NEW YORK, Dec. 27, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

http://www.reportlinker.com/p0739466/Europe-Diabetes-Care-Devices-Market-Outlook-to-2017--Glucose-Monitoring-and-Insulin-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Summary

GlobalData's new report, "Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery" provides key market data on the Europe Diabetes Care Devices market – France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include France, Germany, Italy, Spain and United Kingdom.

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the Europe Diabetes Care Devices market..

- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Novo Nordisk A/S, Eli Lilly and Company, LifeScan, Inc., Medtronic, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Europe Diabetes Care Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 11

2.1 What is This Report About? 11

3 Diabetes Care Devices in Europe 12

3.1 Diabetes Care Devices Cross Country Comparison, USD Actual, 2003-2017 12

3.2 Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, 2003-2017 13

3.3 Diabetes Care Devices, Europe, Category Volume (Units), 2003-2017 17

3.4 Diabetes Care Devices, Europe, Company share (2009-2010) 20

4 Diabetes Care Devices In Germany 22

4.1 Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, 2003-2017 22

4.2 Diabetes Care Devices, Germany, Category Volume (Units), 2003-2017 27

4.3 Diabetes Care Devices, Germany, Distribution Share (2009-2010) 30

4.3.1 Glucose Monitoring, Germany, Distribution Share (2009-2010) 30

4.3.2 Insulin Delivery, Germany, Distribution Share (2009-2010) 30

4.4 Diabetes Care Devices, Germany, Company share (2009-2010) 31

4.4.1 Glucose Monitoring, Germany, Company share (2009-2010) 33

4.4.2 Insulin Delivery, Germany, Company share (2009-2010) 34

5 Diabetes Care Devices In France 36

5.1 Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, 2003-2017 36

5.2 Diabetes Care Devices, France, Category Volume (Units), 2003-2017 41

5.3 Diabetes Care Devices, France, Distribution Share (2009-2010) 44

5.3.1 Glucose Monitoring, France, Distribution Share (2009-2010) 44

5.3.2 Insulin Delivery, France, Distribution Share (2009-2010) 44

5.4 Diabetes Care Devices, France, Company share (2009-2010) 45

5.4.1 Diabetes Care Devices, France, Company share (2009-2010) 45

5.4.2 Glucose Monitoring, France, Company share (2009-2010) 47

5.4.3 Insulin Delivery, France, Company share (2009-2010) 48

6 Diabetes Care Devices In Italy 50

6.1 Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, 2003-2017 50

6.2 Diabetes Care Devices, Italy, Category Volume (Units), 2003-2017 55

6.3 Diabetes Care Devices, Italy, Distribution Share (2009-2010) 58

6.3.1 Glucose Monitoring, Italy, Distribution Share (2009-2010) 58

6.3.2 Insulin Delivery, Italy, Distribution Share (2009-2010) 58

6.4 Diabetes Care Devices, Italy, Company share (2009-2010) 59

6.4.1 Diabetes Care Devices, Italy, Company share (2009-2010) 59

6.4.2 Glucose Monitoring, Italy, Company share (2009-2010) 61

6.4.3 Insulin Delivery, Italy, Company share (2009-2010) 62

7 Diabetes Care Devices In Spain 64

7.1 Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, 2003-2017 64

7.2 Diabetes Care Devices, Spain, Category Volume (Units), 2003-2017 67

7.3 Diabetes Care Devices, Spain, Distribution Share (2009-2010) 70

7.3.1 Glucose Monitoring, Spain, Distribution Share (2009-2010) 70

7.3.2 Insulin Delivery, Spain, Distribution Share (2009-2010) 70

7.4 Diabetes Care Devices, Spain, Company share (2009-2010) 71

7.4.1 Diabetes Care Devices, Spain, Company share (2009-2010) 71

7.4.2 Glucose Monitoring, Spain, Company share (2009-2010) 73

7.4.3 Insulin Delivery, Spain, Company share (2009-2010) 74

8 Diabetes Care Devices In United Kingdom 76

8.1 Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, 2003-2017 76

8.2 Diabetes Care Devices, United Kingdom, Category Volume (Units), 2003-2017 82

8.3 Diabetes Care Devices, United Kingdom, Distribution Share (2009-2010) 85

8.3.1 Glucose Monitoring, United Kingdom, Distribution Share (2009-2010) 85

8.3.2 Insulin Delivery, United Kingdom, Distribution Share (2009-2010) 85

8.4 Diabetes Care Devices, United Kingdom, Company Share (2009-2010) 86

8.4.1 Diabetes Care Devices, United Kingdom, Company Share (2009-2010) 86

8.4.2 Glucose Monitoring, United Kingdom, Company Share (2009-2010) 88

8.4.3 Insulin Delivery, United Kingdom, Company Share (2009-2010) 89

9 Overview of Key Companies in Europe Diabetes Care Devices Market 91

9.1 F. Hoffmann-La Roche Ltd. 91

9.1.1 Company Overview 91

9.1.2 Share in the Europe Diabetes Care Devices Market 91

9.2 Sanofi 92

9.2.1 Company Overview 92

9.2.2 Share in the Europe Diabetes Care Devices Market 92

9.3 Novo Nordisk A/S 93

9.3.1 Company Overview 93

9.3.2 Share in the Europe Diabetes Care Devices Market 93

9.4 Eli Lilly and Company 94

9.4.1 Company Overview 94

9.4.2 Share in the Europe Diabetes Care Devices Market 94

9.5 LifeScan, Inc. 95

9.5.1 Company Overview 95

9.5.2 Share in the Europe Diabetes Care Devices Market 95

9.6 Medtronic, Inc. 96

9.6.1 Company Overview 96

9.6.2 Share in the Europe Diabetes Care Devices Market 96

9.7 Becton, Dickinson and Company 97

9.7.1 Company Overview 97

9.8 Bayer HealthCare AG 97

9.8.1 Company Overview 97

9.9 Abbott Laboratories 97

9.9.1 Company Overview 97

9.10 Ypsomed Holding AG 98

9.10.1 Company Overview 98

9.11 Animas Corporation 98

9.11.1 Company Overview 98

9.12 NIPRO CORPORATION 98

9.12.1 Company Overview 98

9.13 ARKRAY, Inc. 99

9.13.1 Company Overview 99

9.14 Terumo Corporation 99

9.14.1 Company Overview 99

9.15 B. Braun Melsungen AG 99

9.15.1 Company Overview 99

10 Diabetes Care Devices Market Pipeline Products 100

11 Financial Deals Landscape 103

11.1 Acquisition 103

11.1.1 Mediq Acquires PBG from Mentha Capital 103

11.2 Partnerships 104

11.2.1 Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 104

11.2.2 EyeSense Enters Into An Agreement With QIAGEN 105

12 Recent Developments 106

12.1 Strategy And Business Planning 106

12.1.1 Nov 02, 2011: Sanofi To Shut Down R&D Site In Bridgewater, New Jersey 106

12.1.2 Oct 13, 2011: Unisense Establishes US Headquarter 106

12.1.3 Aug 25, 2011: Novo Nordisk To Build New Corporate Center In Bagsvaerd, Denmark 106

12.1.4 Jul 25, 2011: LEUKOCARE And Sanofi Pasteur Sign Cooperation Agreement For Vaccine Stabilization 107

12.1.5 Jun 23, 2011: Roche Sets Up R&D Institute In France To Foster Collaborative Translational Research 107

12.1.6 Apr 04, 2011: Sanofi-aventis's European Generic Pharmaceuticals Businesses To Operate Under Unified Brand Name Zentiva 107

12.2 Government and Public Interest 108

12.2.1 Jan 27, 2011: China's Ministry Of Commerce Grants Clearance For Merger Of BMP Sunstone And sanofi-aventis Subsidiary 108

12.3 Product News 108

12.3.1 Apr 06, 2010: Study Finds Gene Linking Lower Birth Weight And Type 2 Diabetes 108

13 Appendix 110

13.1 Definitions of Markets Covered in the Report 111

13.1.1 Diabetes Care Devices 111

13.2 Research Methodology 112

13.3 Secondary Research 112

13.4 Primary Research 113

13.5 Models 113

13.6 Forecasts 114

13.7 Expert Panels 114

13.8 GlobalData Consulting 114

13.9 Currency Conversion 115

13.10 Contact Us 115

13.11 Disclaimer 115

List of Tables

Table 1: Diabetes Care Devices, Cross Country Comparison, USD Actual, 2003-2017 12

Table 2: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, 2003-2017 13

Table 3: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14

Table 4: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 16

Table 5: Diabetes Care Devices, Europe, Category Volume (Units), 2003-2017 17

Table 6: Diabetes Care Devices, Europe, Category Volume (Units), Historic, 2003-2010 18

Table 7: Diabetes Care Devices, Europe, Category Volume (Units), Forecast, 2010-2017 19

Table 8: Diabetes Care Devices, Europe, Company share by Revenue ($m), USD Actual, 2009-2010 21

Table 9: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, 2003-2017 22

Table 10: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, Historic, 2003-2010 24

Table 11: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 26

Table 12: Diabetes Care Devices, Germany, Category Volume (Units), 2003-2017 27

Table 13: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2003-2010 28

Table 14: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2010-2017 29

Table 15: Glucose Monitoring, Germany, Distribution Share by Revenue ($m), USD Actual, 2009-2010 30

Table 16: Insulin Delivery, Germany, Distribution Share by Revenue ($m), USD Actual, 2009-2010 30

Table 17: Diabetes Care Devices, Germany, Company share by Revenue ($m), USD Actual, 2009-2010 32

Table 18: Glucose Monitoring, Germany, Company share by Revenue ($m), USD Actual 2009-2010 33

Table 19: Insulin Delivery, Germany, Company share by Revenue ($m), USD Actual 2009-2010 35

Table 20: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, 2003-2017 36

Table 21: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, Historic, 2003-2010 38

Table 22: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 40

Table 23: Diabetes Care Devices, France, Category Volume (Units), 2003-2017 41

Table 24: Diabetes Care Devices, France, Category Volume (Units), Historic, 2003-2010 42

Table 25: Diabetes Care Devices, France, Category Volume (Units), Forecast, 2010-2017 43

Table 26: Glucose Monitoring, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44

Table 27: Insulin Delivery, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44

Table 28: Diabetes Care Devices, France, Company share by Revenue ($m), USD Actual, 2009-2010 46

Table 29: Glucose Monitoring, France, Company share by Revenue ($m), USD Actual 2009-2010 47

Table 30: Insulin Delivery, France, Company share by Revenue ($m), USD Actual 2009-2010 49

Table 31: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, 2003-2017 50

Table 32: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, Historic, 2003-2010 52

Table 33: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 54

Table 34: Diabetes Care Devices, Italy, Category Volume (Units), 2003-2017 55

Table 35: Diabetes Care Devices, Italy, Category Volume (Units), Historic, 2003-2010 56

Table 36: Diabetes Care Devices, Italy, Category Volume (Units), Forecast, 2010-2017 57

Table 37: Glucose Monitoring, Italy, Distribution Share by Revenue ($m), USD Actual, 2009-2010 58

Table 38: Insulin Delivery, Italy, Distribution Share by Revenue ($m), USD Actual, 2009-2010 58

Table 39: Diabetes Care Devices, Italy, Company share by Revenue ($m), USD Actual, 2009-2010 60

Table 40: Glucose Monitoring, Italy, Company share by Revenue ($m), USD Actual 2009-2010 61

Table 41: Insulin Delivery, Italy, Company share by Revenue ($m), USD Actual 2009-2010 63

Table 42: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, 2003-2017 64

Table 43: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, Historic, 2003-2010 65

Table 44: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 66

Table 45: Diabetes Care Devices, Spain, Category Volume (Units), 2003-2017 67

Table 46: Diabetes Care Devices, Spain, Category Volume (Units), Historic, 2003-2010 68

Table 47: Diabetes Care Devices, Spain, Category Volume (Units), Forecast, 2010-2017 69

Table 48: Glucose Monitoring, Spain, Distribution Share by Revenue ($m), USD Actual, 2009-2010 70

Table 49: Insulin Delivery, Spain, Distribution Share by Revenue ($m), USD Actual, 2009-2010 70

Table 50: Diabetes Care Devices, Spain, Company share by Revenue ($m), USD Actual, 2009-2010 72

Table 51: Glucose Monitoring, Spain, Company share by Revenue ($m), USD Actual 2009-2010 73

Table 52: Insulin Delivery, Spain, Company share by Revenue ($m), USD Actual 2009-2010 75

Table 53: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, 2003-2017 77

Table 54: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Historic, 2003-2010 79

Table 55: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 81

Table 56: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2003-2017 82

Table 57: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 83

Table 58: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 84

Table 59: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($m), USD Actual, 2009-2010 85

Table 60: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($m), USD Actual, 2009-2010 85

Table 61: Diabetes Care Devices, United Kingdom, Company Share by Revenue ($m), USD Actual, 2009-2010 87

Table 62: Glucose Monitoring, United Kingdom, Company Share by Revenue ($m), USD Actual 2009-2010 88

Table 63: Insulin Delivery, United Kingdom, Company Share by Revenue ($m), USD Actual 2009-2010 90

Table 64: Diabetes Care Devices Market Pipeline Products 100

Table 65: Mediq Acquires PBG From Mentha Capital 103

Table 66: Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 104

Table 67: EyeSense Enters Into An Agreement With QIAGEN 105

Table 68: USD to Local Currency, Europe, Average Exchange Rate 2003-2010 115

List of Figures

Figure 1: Diabetes Care Devices, Cross Country Comparison, USD Actual, 2003-2017 12

Figure 2: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, 2003-2017 13

Figure 3: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14

Figure 4: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 15

Figure 5: Diabetes Care Devices, Europe, Category Volume (Units), 2003-2017 17

Figure 6: Diabetes Care Devices, Europe, Category Volume (Units), Historic, 2003-2010 18

Figure 7: Diabetes Care Devices, Europe, Category Volume (Units), Forecast, 2010-2017 19

Figure 8: Diabetes Care Devices, Europe, Company share (%), 2010 20

Figure 9: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, 2003-2017 22

Figure 10: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, Historic, 2003-2010 23

Figure 11: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 25

Figure 12: Diabetes Care Devices, Germany, Category Volume (Units), 2003-2017 27

Figure 13: Diabetes Care Devices, Germany, Category Volume (Units), Historic, 2003-2010 28

Figure 14: Diabetes Care Devices, Germany, Category Volume (Units), Forecast, 2010-2017 29

Figure 15: Diabetes Care Devices, Germany, Company share (%), 2010 31

Figure 16: Glucose Monitoring, Germany, Company share (%), 2010 33

Figure 17: Insulin Delivery, Germany, Company share (%), 2010 34

Figure 18: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, 2003-2017 36

Figure 19: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, Historic, 2003-2010 37

Figure 20: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 39

Figure 21: Diabetes Care Devices, France, Category Volume (Units), 2003-2017 41

Figure 22: Diabetes Care Devices, France, Category Volume (Units), Historic, 2003-2010 42

Figure 23: Diabetes Care Devices, France, Category Volume (Units), Forecast, 2010-2017 43

Figure 24: Diabetes Care Devices, France, Company share (%), 2010 45

Figure 25: Glucose Monitoring, France, Company share (%), 2010 47

Figure 26: Insulin Delivery, France, Company share (%), 2010 48

Figure 27: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, 2003-2017 50

Figure 28: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, Historic, 2003-2010 51

Figure 29: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 53

Figure 30: Diabetes Care Devices, Italy, Category Volume (Units), 2003-2017 55

Figure 31: Diabetes Care Devices, Italy, Category Volume (Units), Historic, 2003-2010 56

Figure 32: Diabetes Care Devices, Italy, Category Volume (Units), Forecast, 2010-2017 57

Figure 33: Diabetes Care Devices, Italy, Company share (%), 2010 59

Figure 34: Glucose Monitoring, Italy, Company share (%), 2010 61

Figure 35: Insulin Delivery, Italy, Company share (%), 2010 62

Figure 36: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, 2003-2017 64

Figure 37: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, Historic, 2003-2010 65

Figure 38: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 66

Figure 39: Diabetes Care Devices, Spain, Category Volume (Units), 2003-2017 67

Figure 40: Diabetes Care Devices, Spain, Category Volume (Units), Historic, 2003-2010 68

Figure 41: Diabetes Care Devices, Spain, Category Volume (Units), Forecast, 2010-2017 69

Figure 42: Diabetes Care Devices, Spain, Company share (%), 2010 71

Figure 43: Glucose Monitoring, Spain, Company share (%), 2010 73

Figure 44: Insulin Delivery, Spain, Company share (%), 2010 74

Figure 45: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, 2003-2017 76

Figure 46: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Historic, 2003-2010 78

Figure 47: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 80

Figure 48: Diabetes Care Devices, United Kingdom, Category Volume (Units), 2003-2017 82

Figure 49: Diabetes Care Devices, United Kingdom, Category Volume (Units), Historic, 2003-2010 83

Figure 50: Diabetes Care Devices, United Kingdom, Category Volume (Units), Forecast, 2010-2017 84

Figure 51: Diabetes Care Devices, United Kingdom, Company Share (%), 2010 86

Figure 52: Glucose Monitoring, United Kingdom, Company Share (%), 2010 88

Figure 53: Insulin Delivery, United Kingdom, Company Share (%), 2010 89

Figure 54: F. Hoffmann-La Roche Ltd., Company Share (%), Europe Diabetes Care Devices Market, 2010 91

Figure 55: Sanofi, Company Share (%), Europe Diabetes Care Devices Market, 2010 92

Figure 56: Novo Nordisk A/S, Company Share (%), Europe Diabetes Care Devices Market, 2010 93

Figure 57: Eli Lilly and Company, Company Share (%), Europe Diabetes Care Devices Market, 2010 94

Figure 58: LifeScan, Inc., Company Share (%), Europe Diabetes Care Devices Market, 2010 95

Figure 59: Medtronic, Inc., Company Share (%), Europe Diabetes Care Devices Market, 2010 96

Companies mentioned

F. Hoffmann-La Roche Ltd.

Sanofi

Novo Nordisk A/S

Eli Lilly and Company

LifeScan, Inc.

Medtronic, Inc.

Becton, Dickinson and Company

Bayer HealthCare AG

Abbott Laboratories

Ypsomed Holding AG

Animas Corporation

NIPRO CORPORATION

ARKRAY, Inc.

Terumo Corporation

B. Braun Melsungen AG

To order this report:

Pathology Industry: Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

More  Market Research Report

Check our  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
3. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
4. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
5. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
6. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
7. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
8. BioMosaics Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
11. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):